Buscar resultados de ensayos clínicos

Patrocinado por

Acinic Cell Carcinoma - 45 Studies Found

Estado Estudiar
Suspended Nombre del estudio: Selinexor, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Metastatic Pancreatic Cancer
Condición:
  • Acinar Cell Adenocarcinoma of the Pancreas
  • Duct Cell Adenocarci
    Fecha: 2014-06-23
    Intervenciones:
    • Drug: gemcitabine hydrochloride

Completed Nombre del estudio: Ultrasound-Guided Photodynamic Therapy With Photofrin & Gemcitabine for Patients With Locally Advanced Pancreatic Cancer
Condición:
  • Acinar Cell Adenocarcinoma of the Pancreas
  • Duct Cell Adenocarci
    Fecha: 2013-01-15
    Intervenciones:
    • Drug: porfimer sodium Given IV
Completed Nombre del estudio: Bortezomib and Carboplatin in Treating Patients With Metastatic Pancreatic Cancer
Condición:
  • Acinar Cell Adenocarcinoma of the Pancreas
  • Duct Cell Adenocarci
    Fecha: 2006-12-27
    Intervenciones:
    • Drug: bortezomib Given IV
Completed Nombre del estudio: Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy
Condición:
  • Pancreatic Acinar Cell Carcinoma
  • Pancreatic Ductal Adenocarcino
    Fecha: 2012-08-03
    Intervenciones:
    • Drug: Akt Inhibitor MK2206 Giv
Active, not recruiting Nombre del estudio: Carboplatin and Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Metastatic Pancreatic Cancer
Condición:
  • Pancreatic Acinar Cell Carcinoma
  • Pancreatic Ductal Adenocarcino
    Fecha: 2011-01-18
    Intervenciones:
    • Drug: Carboplatin Given IV
Active, not recruiting Nombre del estudio: Vaccine Therapy and Sargramostim in Treating Patients With Pancreas Cancer That Cannot Be Removed By Surgery
Condición:
  • Pancreatic Acinar Cell Carcinoma
  • Pancreatic Ductal Adenocarcino
    Fecha: 2008-04-29
    Intervenciones:
    • Biological: Falimarev Given in
Completed Nombre del estudio: Stereotactic Radiosurgery and Metformin Hydrochloride in Treating Patients With Borderline-Resectable or Locally-Advanced Pancreatic Cancer
Condición:
  • Acinar Cell Adenocarcinoma of the Pancreas
  • Duct Cell Adenocarci
    Fecha: 2014-05-30
    Intervenciones:
    • Drug: metformin hydrochloride

Active, not recruiting Nombre del estudio: CPI-613 and Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer
Condición:
  • Acinar Cell Adenocarcinoma of the Pancreas
  • Duct Cell Adenocarci
    Fecha: 2013-04-16
    Intervenciones:
    • Drug: 6,8-bis(benzylthio)octanoic acid

Active, not recruiting Nombre del estudio: Chemoradiation and Radiosurgery Boost in Treating Patients With Locally Advance Pancreatic Cancer That May or May Not be Removed by Surgery
Condición:
  • Acinar Cell Adenocarcinoma of the Pancreas
  • Duct Cell Adenocarci
    Fecha: 2012-11-29
    Intervenciones:
    • Drug: gemcitabine hydrochloride

Completed Nombre del estudio: Metformin Plus Modified FOLFOX 6 in Metastatic Pancreatic Cancer
Condición:
  • Acinar Cell Adenocarcinoma of the Pancreas
  • Duct Cell Adenocarci
    Fecha: 2012-08-14
    Intervenciones:
    • Drug: metformin hydrochloride

Next >>>